Disease-Modifying Antirheumatic Drugs Increase Serum Adiponectin Levels in Patients With Rheumatoid Arthritis


Cansu B. , Cansu D. U. , Kasifoglu T., Gulbas Z., Korkmaz C.

JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, cilt.17, ss.14-17, 2011 (SCI İndekslerine Giren Dergi) identifier identifier identifier

  • Cilt numarası: 17 Konu: 1
  • Basım Tarihi: 2011
  • Doi Numarası: 10.1097/rhu.0b013e318204a587
  • Dergi Adı: JCR-JOURNAL OF CLINICAL RHEUMATOLOGY
  • Sayfa Sayıları: ss.14-17

Özet

Background: Adiponectin is an adipocyte-derived adipokine with immunosuppressive and anti-inflammatory properties. It also decreases expression of adhesion molecules. In terms of its relationship with acute-phase reactants, there are conflicting results in patients with rheumatoid arthritis (RA).